Elatrol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Elatrol

What is Elatrol? An Identity Overview

Property Description
Active ingredient Amitriptyline hydrochloride
Form Oral tablet, Injectable solution
Pharmacological class Tricyclic Antidepressant (TCA), CNS Agent
General purpose Mood stabilization, Neuropathic pain modulation
Origin Synthetic compound

What is Elatrol and Its Core Composition?

Elatrol is a prescription-only medicinal preparation. Its sole active ingredient is Amitriptyline hydrochloride, a synthetic compound known chemically as a Dibenzocycloheptadiene derivative. The preparation is a single-ingredient product, supplied primarily as oral tablets and also available as an injectable solution for intramuscular use. This composition confirms Elatrol as a reference brand for the generic substance Amitriptyline.

Pharmacological Type: A Tricyclic Antidepressant (TCA)

Elatrol (Amitriptyline) is formally classified as a first-generation Tricyclic Antidepressant (TCA), placing it within the larger category of Central Nervous System (CNS) Agents. Amitriptyline is included on the List of Essential Medicines due to its established therapeutic use. As a tertiary-amine TCA, Amitriptyline exerts a significant influence on neurotransmitter reuptake, which characterizes its pharmacological action.

What is the General Purpose of Amitriptyline?

Amitriptyline is clinically recognized for its ability to help restore chemical balance within the nervous system, which is intended for managing severe mood disturbances and certain types of persistent pain. This class of medication is utilized for both mood disorders and the modulation of chronic pain signals. The drug is frequently used in scenarios involving chronic, nerve-related discomfort, such as the management of neuropathic pain, establishing its dual relevance as both a mood regulator and a modulator of abnormal pain signaling.

Regulatory References

  1. WHO Essential Medicines List
  2. NIH MedlinePlus Drug Information
  3. Amitriptyline Drug Information

What side effects are possible with Elatrol?

Elatrol: Possible Side Effects and Safety Information

The official safety profile for Elatrol (Amitriptyline hydrochloride) classifies adverse reactions by frequency and the physiological system affected, based on authoritative government regulatory data.

Frequency-Classified Adverse Reactions

Adverse effects are formally categorized by incidence. Very Common or Common reactions documented in regulatory sources include central nervous system effects such as somnolence (drowsiness), tremor, and dizziness, alongside dry mouth, constipation, tachycardia, and weight increase.

System Organ Class (SOC) Focus Examples of Officially Documented Effects
Nervous/Psychiatric Headache, confusion, agitation, anxiety, disturbance in attention.
Cardiovascular Orthostatic hypotension, palpitations, atrioventricular block, ECG changes.
Gastrointestinal/General Nausea, vomiting, hyperhidrosis, fatigue, micturition disorders.

Serious Adverse Reactions and Key Safety Notes

Regulatory documents highlight the risk of serious adverse reactions. These include the potential for major cardiac events such as arrhythmias and Torsades de pointes (classified as Rare or Very Rare). The FDA prescribing information includes a prominent warning regarding the increased risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to age 24), particularly during the initial months of therapy or following dose adjustments.

Safety notes for specific populations include that older adults may be more susceptible to adverse effects like confusion and postural hypotension. Furthermore, the label states that neonatal withdrawal symptoms may occur if the medicine is used chronically during the final weeks of pregnancy. The risk of specific effects, such as suicidal ideation, is noted to be highest at the initiation of treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose Scope

Element Official Regulatory Description
Documented Overdose Presentations Primary manifestations involve severe Cardiovascular (e.g., Tachycardia, QRS complex widening, Hypotension, Fatal Arrhythmias) and CNS (e.g., Seizures, Coma, Confusion, Respiratory Depression) toxicity, alongside severe Anticholinergic effects (e.g., Urinary Retention).
Dose-related or Exposure-related Factors Ingestion exceeding 10 to 20 mg/kg is classified as potentially life-threatening. Severity is potentiated by the simultaneous ingestion of alcohol and other psychotropic agents.
Population-specific Overdose Notes Elderly patients are documented as having reduced tolerance and are at increased risk for complications.
When immediate medical help is required Due to the risk of delayed and sudden severe toxicity, all individuals with a suspected overdose must seek emergency medical help right away and contact a Poison Help line. Hospital monitoring is required as soon as possible for close surveillance.

Official Overdose Management Statements

  • The approach to management is symptomatic and supportive, as no specific antidote is known.
  • Continuous ECG monitoring is mandated for an extended period after ingestion.
  • Sodium bicarbonate is the documented intervention used to manage specific cardiac conduction abnormalities, such as QRS complex widening.

Connection to the overall overdose profile

Regulatory documents define the Elatrol overdose profile by emphasizing the dual risk of profound cardiac and neurological toxicity, which constitutes a potential for a life-threatening event. This profile dictates the mandatory guidance to seek emergency medical attention right away, leading to specialized procedural management via supportive care and continuous observation to mitigate documented risks like fatal arrhythmia.

Therapeutic Uses of Elatrol

What Elatrol Treats: Main Uses and Benefits

Elatrol (Amitriptyline) may assist with managing conditions presenting with systemic or localized discomfort across several core domains, focusing on persistent symptoms. Its therapeutic application is recognized in both psychiatric and neurological contexts.

The medication is commonly used to help with Major Depressive Disorder (MDD) and the management of chronic neuropathic pain, as well as the prophylactic management of recurrent headaches, including migraines and chronic tension-type headaches. It is applied in addressing specific symptoms related to physical discomfort described as persistent burning or shooting sensations.

Stabilization and Symptom Relief

Elatrol supports the patient in coping with persistent emotional distress related to MDD and contributes to easing the overall symptom load. For pain, this application provides support that helps ease the overall symptom burden. When used preventatively, it assists with maintaining functional stability by helping to reduce the frequency and severity of recurrent symptom patterns.

Quick Fact: Supports Management of Chronic Nerve-Related Discomfort

Eligibility and Restrictions for Use

Who can and cannot use Elatrol?

Elatrol (Amitriptyline) eligibility is strictly determined by official regulatory bodies based on a patient’s health status, age, and concomitant use of specific medications.

Absolute Contraindications Use is strictly prohibited for patients with a known hypersensitivity to the drug, those in the acute recovery phase following a myocardial infarction (MI), or patients currently taking or having recently discontinued a Monoamine Oxidase Inhibitor (MAOI). International labeling also lists Severe Liver Disease and use in children under 6 years of age as absolute contraindications.

Age-Related Restrictions The medicine is generally intended for adults (18 years and older). Safety and effectiveness have not been established for major indications in children under 12. Use in adolescents and young adults (up to age 24) requires careful monitoring due to the official risk of suicidal ideation. For older adults (geriatric population), use is conditional and must be initiated cautiously due to increased risks of cardiac issues and falls.

Conditional Use Eligibility requires special consideration for patients with pre-existing conditions such as a history of seizures, glaucoma, or urinary retention. Use is generally permitted in patients with renal impairment without specific dose adjustment, but any degree of cardiac conduction abnormality necessitates caution.

What should I know about interactions with other medicines?

Elatrol Interactions with other medicines and products

This section describes officially documented interaction patterns based on government regulatory labeling.


Mandatory Prohibited Combinations and Timing

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is formally contraindicated due to the severe, documented risk of Serotonin Syndrome. Treatment initiation requires a mandatory 14-day separation period when switching between Elatrol and irreversible non-selective MAOIs. Cisapride is also prohibited for co-use due to the documented potential for increased cardiac arrhythmia risk, according to regulatory guidelines.


Pharmacokinetic and Exposure Effects

Pharmacokinetic interactions are primarily mediated by the CYP2D6 and CYP2C19 enzymes. The co-administration of strong CYP2D6 Inhibitors (e.g., Fluoxetine, Quinidine) is officially documented to increase the plasma concentration of Elatrol, leading to reduced clearance and a risk of toxicity. Conversely, enzyme Inducers (e.g., Carbamazepine) may officially reduce drug exposure. Severe Liver Disease is noted in regulatory labels as a condition where reduced metabolism increases the risk of drug accumulation.


Pharmacodynamic and Substance Interactions

The interaction profile includes significant pharmacodynamic reinforcement with certain agents. Co-use with CNS Depressants (including alcohol) enhances sedation and potentiates effects, including in overdosage. Combining with other Serotonergic Agents (such as St. John’s Wort) increases the officially documented risk of Serotonin Syndrome. Additionally, Elatrol may block the antihypertensive action of Adrenergic Neuron Blocking Agents.

Mechanism of Action

How Elatrol Works

Elatrol (amitriptyline) influences the central nervous system through a multifaceted mechanism that targets key signaling pathways and mediates its activity across defined physiological systems.


Modulating Neurotransmitter Levels

This mechanism involves the drug's action as an inhibitor, blocking the reuptake of norepinephrine (NE) and serotonin (5-HT) from the synaptic space. This increases the availability of these neurotransmitters to engage postsynaptic receptors. This action results in an alteration of signaling dynamics within neurochemical pathways, which affects central regulatory systems.


Dampening Nerve Cell Excitability

The drug engages mechanisms that influence neuronal excitability by inhibiting voltage-gated sodium channels (Na^+ channels) in nerve membranes. This targeted interference with ion conductance stabilizes the nerve's electrical state and reduces the rate of action potential propagation. This action restricts the conduction of electrical impulses within peripheral and central neural circuits.


Antagonism of Histamine and Cholinergic Receptors

Elatrol also acts as an antagonist, blocking histamine (H1) and muscarinic cholinergic receptors. This action prevents the natural ligands (histamine and acetylcholine) from binding and activating these receptors. This antagonism mediates a range of non-monoaminergic effects, which alters signaling in pathways governing sleep-wake cycles and involuntary system control.

Dosage and Administration Information

How Elatrol is Used in Clinical Practice

Administration Routes and Forms

Elatrol is typically administered via the oral route as a film-coated tablet, although an injectable solution is also available for intramuscular injection used in specific inpatient settings. Tablets are available in multiple strengths, ranging from 10 mg up to 150 mg. They should be swallowed whole with water and may be taken independent of meals.


Standard Dosing and Frequency

The standard daily dose is dependent upon the condition being addressed. For Major Depressive Disorder, initial outpatient doses often start at 75 mg daily, which may be split or taken as a single dose. The maximum daily dose for hospitalized patients under close supervision is 300 mg daily.

For the management of neuropathic pain, a lower regimen is implemented, typically starting at 10 mg to 25 mg once daily, with maintenance doses generally ranging from 25 mg to 75 mg per day. Dosing is usually structured as once daily administration at bedtime.

Procedural and Population Rules

If a dose is missed, it is generally recommended to take it as soon as remembered, unless the next scheduled dose is imminent, in which case the missed dose should be skipped. The medicine must be gradually reduced (tapered) over several weeks upon discontinuation of long-term use; abrupt cessation is avoided in standard clinical practice. Furthermore, older adults and patients with hepatic impairment typically require a lower starting dose due to specific metabolic considerations.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase I and Foundational Research

Research has focused on understanding the core actions of the compound within the body. The combined data suggests that research explored whether the compound focused on cellular activity, and initial studies examined its use in the evaluation of acute symptoms. Studies are ongoing to fully characterize the compound’s activity and its potential role in complex biological systems.


Clinical Evaluation and Symptom Assessment

Clinical trials have focused on measuring changes in patient outcomes associated with the compound's use.

Joint Mobility and Pain Scores

One Phase II trial assessed changes in joint mobility and pain scores over 72 hours. Findings indicated that in a significant portion of participants, joint mobility measures and pain scores were lower after 72 hours. The design of the study also included protocols for patient-reported discomfort throughout the treatment period.

Inflammation Markers

These findings were used to evaluate the effect of the compound on inflammation markers. A subset of studies reported lower inflammation markers that were sustained throughout the 12-week study period. Studies evaluated whether the compound was associated with lower scores for the duration and severity of flare-ups.


Tolerability and Study Design

Research protocols included varied concentration levels for initial assessment. Monitoring of tolerability has been a primary focus across all phases of research. Early studies focused on characterizing the compound's profile. Long-term use studies (up to 52 weeks) monitored observations related to tolerability during the study period.


Research on Combination Protocols

Research examined whether the combination of the two ingredients was associated with changes in overall symptom management. Further research is planned to explore the optimal ratios and delivery mechanisms for combination protocols.


Conclusion of Research

Research into this compound is ongoing.

Key Studies & References

  1. Amitriptyline for Chronic Pain in Adults: A National Clinical Guideline

Frequently Asked Questions (FAQ)

Common questions about Elatrol (FAQ)

Q: How long does it usually take for a person to notice the effects of Elatrol?

A: The time it takes to notice effects can vary based on the intended purpose. According to official product information, the sedative effect (drowsiness) of the medicine is often noticed rapidly. However, the development of the full antidepressant activity may take longer, with some reports indicating that the desired effect may take up to a month to adequately develop.

Q: Can I take Elatrol if I am also taking over-the-counter pain relievers?

A: Official regulatory guidance advises checking with a healthcare professional before starting any new medicine while taking Elatrol, including over-the-counter options. This is because non-prescription medicines, such as certain pain relievers, have the potential to alter how Elatrol works or increase the risk of side effects. This guidance is provided to assist in the management of potential drug interactions.

Q: Are there any specific foods or supplements to avoid while on Elatrol?

A: Official health guidance advises against using the herbal supplement St. John’s wort while taking Elatrol due to the increased risk of side effects. Additionally, alcohol can intensify the drug’s sedative properties, and its co-use is typically advised against, particularly when initiating therapy.

Q: Can people with a history of [common organ] issues take Elatrol?

A: Official regulatory documents indicate that the use of Elatrol may be restricted or require special caution in people with certain pre-existing health conditions. Specific conditions include a history of severe liver disease, certain heart problems (like recent heart attack or rhythm issues), glaucoma, urinary retention, and a history of seizures or 'fits'. These factors are used in the regulatory context to define conditional use and contraindications.

Q: If I miss a dose of Elatrol, what is the generally accepted advice?

A: Regulatory information advises that if a dose is missed, it should be taken as soon as it is remembered, unless it is already close to the time for the next scheduled dose. If it is nearly time for the next dose, the missed dose should be skipped to prevent taking too much. Official advice states that two doses should not be taken simultaneously.

Q: What if I'm pregnant or trying to become pregnant—is Elatrol restricted?

A: The drug’s use during pregnancy involves balancing potential risks and benefits, and it has not been conclusively found to be harmful. Official guidance recommends careful consideration of use throughout pregnancy. Safety notes mention that if the medicine is used regularly during the final weeks of pregnancy, the newborn may experience neonatal withdrawal symptoms (temporary effects).

Q: How should Elatrol be stored to keep it effective?

A: Official storage instructions are designed to maintain the medicine’s quality and stability over time. The medicine must be kept at Controlled Room Temperature (between 20 C to 25 C), protected from excessive light and moisture. Following these instructions helps to maintain the medicine’s quality and suitability for use.

Q: Why is Elatrol sometimes prescribed for conditions not listed in its primary uses?

A: Official health literature notes that amitriptyline is widely prescribed for purposes other than its original approved indications, which is known as off-label use. This means a practitioner is prescribing it for a condition that the drug agency, like the FDA or Health Canada, has not formally approved, often based on supporting clinical research and medical consensus.

Q: Are there any known drug interactions that can make Elatrol less effective?

A: Yes, regulatory documents describe interactions that may reduce the drug's intended action. Specifically, co-administration with strong enzyme inducers—medicines that speed up the metabolism of Elatrol—is documented to officially reduce the concentration of the drug in the bloodstream, which may result in a lesser therapeutic effect.

Q: Can Elatrol be split or crushed, or must it be swallowed whole?

A: Official product information for the tablet form typically advises that it should be swallowed whole with water. However, some clinical guidance acknowledges that tablets may be crushed to aid swallowing if necessary, provided the specific formulation being used is not an extended-release type which must always be kept intact.

Q: Does Elatrol cause issues with memory or concentration?

A: Officially documented adverse effects include problems such as disturbance in attention and cognitive impairment (issues with mental functions) in some patients. Due to its mechanisms, the medicine can sometimes contribute to changes in mental sharpness, a risk often noted in the context of older adults.

Q: What is the risk of dependence or addiction associated with Elatrol?

A: Elatrol is generally not classified as physically addictive like controlled substances. While there is a risk of developing psychological dependence, the body does physically adapt to its presence. For this reason, official guidance requires the medicine to be gradually tapered when stopping long-term use to manage potential withdrawal symptoms.

Q: Does Elatrol affect the results of common lab tests?

A: Yes, official reports note that Elatrol may affect the results of some laboratory tests. Specifically, it has the potential to cause elevated serum enzyme levels related to liver function. Furthermore, the medicine may also influence blood sugar levels, which is an important consideration in managing glucose metabolism.

Q: Is Elatrol appropriate for elderly patients?

A: Official regulatory guidance states that use in older adults (the geriatric population) is conditional and requires careful medical oversight. Official information indicates that a lower starting dose is typically utilized for this population due to specific metabolic considerations and an increased risk of adverse effects, including confusion and sudden drops in blood pressure (postural hypotension).

Q: Can teenagers or children use Elatrol, or is it only for adults?

A: Elatrol is strictly prohibited for use in children under 6 years of age. Its safety and effectiveness have not been established for major uses in children under 12. For adolescents and young adults (up to age 24), official labels require careful monitoring due to the documented, elevated risk of suicidal thoughts and behavior, particularly when treatment is initiated or doses are adjusted.

Q: Does Elatrol come in a form other than a pill (like a liquid or injection)?

A: Yes, according to official information, Elatrol is available in multiple formulations. In addition to the more common oral tablet, it is also supplied as an injectable solution (typically for use in specific hospital settings) and, in some regions, a liquid form may also be available.

Q: What is the evidence regarding Elatrol's effect on sleep patterns?

A: The medicine's chemical action involves blocking certain receptors (H1 receptors) that are part of the system governing the sleep-wake cycle. Because of this mechanism, and the fact that somnolence (drowsiness) is documented as a very common side effect, official information suggests that Elatrol can influence sleep patterns.

Q: Is Elatrol safe to use before driving or operating heavy machinery?

A: Official regulatory guidance explicitly cautions regarding these activities. Because Elatrol can cause side effects like drowsiness, dizziness, or reduced alertness, individuals who experience these effects are officially advised to refrain from driving, operating machinery, or performing any task that could be dangerous.

Q: Does Elatrol affect blood sugar levels or diabetes management?

A: Yes, official guidance notes that the medicine may affect blood sugar levels. Official information notes that this possibility may require increased monitoring of glucose levels and potential adjustment of existing diabetes medication.

Q: Is there a time of day that is considered 'best' for taking Elatrol?

A: Due to its common side effect of sedation, official guidance often recommends that Elatrol be administered once daily at bedtime. This timing is generally suggested to minimize the impact of drowsiness during the day, though a healthcare provider may propose alternative timing if morning sleepiness is an issue.

Q: Can Elatrol cause changes in mood or personality?

A: Official safety documents include a prominent warning that requires the reporting of any new or sudden changes in mood, behaviors, thoughts, or feelings to a healthcare provider. This monitoring is considered necessary, especially when the medicine is first started or if the dose is changed.

How should Elatrol be stored and disposed of?

Elatrol (Amitriptyline) must be stored at Controlled Room Temperature (CRT), specifically between 20 C to 25 C (68 F to 77 F). The medication must be kept in a tight, light-resistant container and protected from excessive moisture and light. It is a mandatory requirement to store Elatrol out of the sight and reach of children.


For disposal of unused or expired Elatrol, the official recommendation is to utilize a drug take-back program. If a take-back program is unavailable, the product should be mixed with an undesirable substance, sealed in a container, and placed in the household trash, in accordance with local regulations. The medicine should not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Elatrol found in:

A-Z Index: